MRSA Vaccine
Methicillin-resistant Staphylococcus aureus infection
Pre-clinicalActive
Key Facts
Indication
Methicillin-resistant Staphylococcus aureus infection
Phase
Pre-clinical
Status
Active
Company
About VLP Biotech
VLP Biotech is a private, preclinical-stage biotech firm specializing in vaccine development for infectious diseases using its proprietary recombinant protein platform. The company operates a service-based model for custom antibody production while advancing its own vaccine candidates through early-stage government-funded grants. With a lean structure, it has secured non-dilutive funding from entities like Leidos and the U.S. government's SBIR/STTR programs to fuel its R&D efforts. Its strategy combines contract services with internal pipeline development to address significant unmet medical needs.
View full company profileTherapeutic Areas
Other Methicillin-resistant Staphylococcus aureus infection Drugs
| Drug | Company | Phase |
|---|---|---|
| MRSA Nanobody | VicuTec Biologicals | Pre-clinical |